Sign in to my Account
Not a member? Join the CNS
Update your profile, manage education credits, set communication preferences, and more
< Return to CNS.org
Upon completion of this course, attendees will be able to:
- Discuss the pre-operative assessment of the patient and the role of intraoperative imaging in the treatment of nonfunctioning pituitary adenoma.
- Review the role of mitotic indices in predicting the behavior of pituitary adenoma and the potential role of immune-related biomarkers such as programmed death ligand 1 (PD-L1) in their treatment.
- Evaluate the role of intraoperative imaging including navigation and intraoperative MRI in pituitary surgery.
- Analyze the findings of novel neurosurgical studies; critique the design and methodology of these studies.
- List important areas for further knowledge development and research. Identify the most important ongoing clinical trials.
Nonfunctioning Pituitary Adenoma Guidelines and Contemporary Management
Nonfunctioning Adenoma Guidelines
Paul A. Gardner
Pituitary Adenoma Genomics/Immune-related Biomarkers
Ian F. Dunn
Modern Techniques in Pituitary Surgery
Oral Abstract Presentations
Ian F. Dunn, Paul A. Gardner, Gabriel Zada
Find a Neurosurgeon